LEADER 01644nam  2200385   450 
001 9910688221903321
005 20230624194627.0
024 7 $a10.5772/intechopen.73736
035   $a(CKB)5400000000043905
035   $a(NjHacI)995400000000043905
035   $a(EXLCZ)995400000000043905
100   $a20230624d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAntisense Therapy /$fedited by Shashwat Sharad, Suman Kapur
210  1$aLondon, England :$cIntechOpen,$d2019.
215   $a1 online resource (124 pages)
311   $a1-78985-265-X 
330   $aAntisense Therapy offers a comprehensive, state-of-the art perspective on the role of antisense therapy in the treatment of human disease, with a special focus on cancer. Use of antisense oligonucleotides is a growing field of pharmaceutical and biotech companies and research programs for treatment of several diseases. This book summarizes and presents the best updates, therapeutic principles, methods, and applications in the field and offers meaningful information to move treatment discovery forward.
606   $aMedical genetics$xMoral and ethical aspects
606   $aMedical genetics$xSocial aspects
615  0$aMedical genetics$xMoral and ethical aspects.
615  0$aMedical genetics$xSocial aspects.
676   $a616.042
702   $aSharad$b Shashwat
702   $aKapur$b Suman
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688221903321
996   $aAntisense Therapy$91989643
997   $aUNINA